Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Kindred Biosciences, Inc. (KIN)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 2.1 | 0.2 | 0.2 | | | | | |
| Asset turnover | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -18.8% | -99.0% | -114.5% | -61.4% | -40.8% | -37.8% | -61.9% | -703.9% |
| ROIC (including intangibles) | -19.9% | -70.6% | -135.5% | -61.2% | -43.2% | -47.5% | -31.4% | -346.8% |
| ROE | -23.3% | -76.4% | -56.2% | -37.4% | -38.4% | -35.7% | -27.5% | -6.7% |
| ROA | -16.4% | -54.9% | -48.1% | -34.9% | -36.0% | -34.2% | -26.7% | -6.4% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 5.4 | 79.2 | 167.6 | | | | | |
| Days payables outstanding | 11.4 | 781.0 | 4,028.5 | | | | | |
| Days inventory outstanding | 16.3 | 2,622.8 | 4,021.8 | | | | | |
| Cash conversion cycle | 10.3 | 1,920.9 | 160.9 | | | | | |
|